| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |